These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 9847974)

  • 21. [Use of plethysmography for the evaluation of peripheral blood vessels with particular reference to Raynaud's disease and conditions preceding scleroderma].
    Stroińska W
    Przegl Dermatol; 1967; 54(4):463-9. PubMed ID: 6052346
    [No Abstract]   [Full Text] [Related]  

  • 22. [How to recognize scleroderma].
    Francès C; Ayoub N; Barete S
    Rev Prat; 2002 Nov; 52(17):1884-90. PubMed ID: 12532864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Scleroderma and Raynaud's phenomenon: current pathogenetic interpretations and clinico-therapeutic trends].
    Zelli GP; Cannata P
    Ann Ital Chir; 1981; 53(3):337-43. PubMed ID: 7337317
    [No Abstract]   [Full Text] [Related]  

  • 24. Dyspnea due to pulmonary hypertension and interstitial lung disease in scleroderma: room for improvement in diagnosis and management.
    Racz H; Mehta S
    J Rheumatol; 2006 Sep; 33(9):1723-5. PubMed ID: 16960934
    [No Abstract]   [Full Text] [Related]  

  • 25. Endothelin and collagen vascular disease: a review with special reference to Raynaud's phenomenon and systemic sclerosis.
    Yamane K
    Intern Med; 1994 Oct; 33(10):579-82. PubMed ID: 7827371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thermographic and symptomatic effect of a single dose of sildenafil citrate on Raynaud's phenomenon in patients with systemic sclerosis: a potential treatment.
    Kumar N; Griffiths B; Allen J
    J Rheumatol; 2006 Sep; 33(9):1918-9. PubMed ID: 16960964
    [No Abstract]   [Full Text] [Related]  

  • 27. Pulmonary arterial hypertension in systemic sclerosis: can we predict responders for successful therapy?
    Sasahara AA
    J Rheumatol; 2009 Apr; 36(4):665-6. PubMed ID: 19342719
    [No Abstract]   [Full Text] [Related]  

  • 28. Assessment and management of scleroderma lung disease.
    Bolster MB; Silver RM
    Curr Opin Rheumatol; 1999 Nov; 11(6):508-13. PubMed ID: 10551676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutic management of acral manifestations of systemic sclerosis].
    Meyer MF; Daigeler A; Lehnhardt M; Steinau HU; Klein HH
    Med Klin (Munich); 2007 Mar; 102(3):209-18. PubMed ID: 17345017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Digestive manifestations during systemic scleroderma].
    Gane S; Boicescu L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1989; 41(6):515-20. PubMed ID: 2577013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic connective tissue diseases in India, VI. Raynaud's disease and pre-progressive systemic sclerosis (Pre-PSS).
    Malaviya AN; Narayanan K; Tiwari SC; Khan KM; Raina V; Pande JN
    J Assoc Physicians India; 1983 Oct; 31(10):625-8. PubMed ID: 6671930
    [No Abstract]   [Full Text] [Related]  

  • 32. Diagnosis and management of scleroderma peripheral vascular disease.
    Herrick A
    Rheum Dis Clin North Am; 2008 Feb; 34(1):89-114; vii. PubMed ID: 18329535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Extrahepatic syndromes (vascular manifestations) in patients HCV infection].
    Gembitskiĭ EV; Glazunov AV; Zhiliaev EV; Proskurina TV
    Klin Med (Mosk); 1995; 73(6):51-3. PubMed ID: 8691784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unilateral limited scleroderma-like changes following formation of an arteriovenous fistula.
    Roberts H; Curnow PA
    Australas J Dermatol; 2007 Feb; 48(1):37-9. PubMed ID: 17222301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic sclerosis - a systematic overview: part 1 - disease characteristics and classification, pathophysiologic concepts, and recommendations for diagnosis and surveillance.
    Klein-Weigel P; Opitz C; Riemekasten G
    Vasa; 2011 Jan; 40(1):6-19. PubMed ID: 21283969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary artery hypertension as the presenting feature of systemic sclerosis sine scleroderma.
    Pauling JD; Gunawardena H; Coghlan JG; Easaw J; Suntharalingam J; McHugh NJ
    Rheumatology (Oxford); 2008 Sep; 47(9):1431-2. PubMed ID: 18603658
    [No Abstract]   [Full Text] [Related]  

  • 37. Pulmonary hypertension: diagnosis and management.
    Kiely DG; Elliot CA; Sabroe I; Condliffe R
    BMJ; 2013 Apr; 346():f2028. PubMed ID: 23592451
    [No Abstract]   [Full Text] [Related]  

  • 38. [Strategy for early diagnosis of lung involvement in systemic scleroderma].
    Diot E; Valat C; Boissinot E; Giraudeau B; Asquier E; Guilmot JL; Lemarié E; Diot P
    Rev Mal Respir; 2000 Dec; 17(6):1073-80. PubMed ID: 11217502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of systemic sclerosis.
    Lim IG; Schrieber L
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):953-7. PubMed ID: 12455189
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cardiopathy in systemic sclerosis].
    Valentini G; Maione S
    Recenti Prog Med; 1996 Nov; 87(11):557-63. PubMed ID: 9122540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.